Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Grass sickness 'shares signs with Alzheimer's'
grazing horses
In the UK, around 2 per cent of horses die from EGS every year.
New study finds link between equine and human conditions

A rare nerve condition of horses may share signs with human brain disorders, a new study has found.

This research offers fresh insight into equine grass sickness (EGS), a rare but largely fatal condition of horses. Edinburgh scientists say their research may help to develop new diagnostic tools.

In the UK, around 2 per cent of horses die from EGS every year. It attacks the nerve cells, causing gastric upset and muscle tremors. Sometimes horses can be nursed back to health if the condition is diagnosed early enough, but more often than not it kills within days.

Researchers from the Roslin Institute and Royal (Dick) School of Veterinary Studies hoped to find out more about the cause of this condition, which is as yet unknown.

When they examined nerve tissue from six horses that died from EGS, they found proteins that are commonly found in the brains of humans with Alzheimer's disease - including amyloid protein.

In total, 506 different proteins were found to be altered in horses with EGS.

Lead author Dr Tom Wishart, from the Roslin Institute, said: "This is the first study to show similarities between an apparently unrelated neurodegenerative disease of large animals and human neurological conditions.

"Although the causes of these conditions are unlikely to be shared, the findings suggest that similar mechanisms could be involved in the later stages of disease."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.